Drug Database
Back to search

Poland· PL-100078909

Enterol

A antidiarrheal microorganisms product containing saccharomyces boulardii cncm i-745, registered in Poland by BIOCODEX. The same ATC class is registered in 4 of our 19 countries.

ATC A07FA

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEnterolATCA07FAREGISTER NO.PL-100078909PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about saccharomyces boulardii cncm i-745Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Saccharomyces boulardii cncm i-745 is registered in 4 of 19 countries.

Countries holding a registration under ATC A07FA (antidiarrheal microorganisms), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose
Search saccharomyces boulardii cncm i-745 products by name

Saccharomyces boulardii cncm i-745 · ATC A07FA

4 / 19 countries

  • Finlandprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Saccharomyces boulardii CNCM I-745
Manufacturer
BIOCODEX
Country
Poland (PL)
ATC code
A07FA
ATC class
Antidiarrheal microorganisms
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909990748419
  • gtin
    05909990748426
  • gtin
    05909990887491
  • gtin
    05909991220792
  • gtin
    05909991474706

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A07FA

Antidiarrheal microorganisms, as other registers publish it.

All saccharomyces boulardii cncm i-745 products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5bb102f-4cae-48a2-8fff-3b502a1ce39d
GET /v1/drugs/d5bb102f-4cae-48a2-8fff-3b502a1ce39d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki",
  "source": "urpl",
  "strength": "250 mg",
  "packaging": "05909990748419 ¦ OTC ¦ 11841\n10 kaps.\n05909990748426 ¦ OTC ¦ 11842\n20 kaps. w butelce\n05909990887491 ¦ OTC ¦ 68105\n20 kaps. w blistrach\n05909991220792 ¦ OTC ¦ 108291\n50 kaps.\n05909991474706 ¦ OTC ¦ 143529\n30 kaps. w butelce",
  "substance": "Saccharomyces boulardii CNCM I-745 (liofilizowane drożdżaki) 250 mg",
  "common_name": "Saccharomyces boulardii CNCM I-745",
  "pl_product_id": "100078909",
  "pozwolenie_nr": "07484",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about saccharomyces boulardii cncm i-745.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console